Our results suggest that high levels of IL-1β, IL-6, and MCP-1 (proinflammatory and proangiogenic) and low levels of IL-10 (anti-inflammatory and anti-angiogenic) are involved in the pathogenesis of diabetic macular edema. The gene discussed is CCL2; the disease is diabetic macular edema.